Teladoc Health, Inc. (LON:0LDR)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 1.03 billion. The enterprise value is 1.27 billion.

Market Cap	1.03B
Enterprise Value	1.27B

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	177.47M
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	1.10%
Owned by Institutions (%)	72.84%
Float	175.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	1.00
P/TBV Ratio	n/a
P/FCF Ratio	4.95
P/OCF Ratio	4.74
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.05, with an EV/FCF ratio of 6.11.

EV / Earnings	-7.65
EV / Sales	0.66
EV / EBITDA	60.05
EV / EBIT	n/a
EV / FCF	6.11

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.75.

Current Ratio	2.70
Quick Ratio	2.33
Debt / Equity	0.75
Debt / EBITDA	37.51
Debt / FCF	3.72
Interest Coverage	-8.26

Financial Efficiency

Return on equity (ROE) is -15.42% and return on invested capital (ROIC) is -4.04%.

Return on Equity (ROE)	-15.42%
Return on Assets (ROA)	-3.48%
Return on Invested Capital (ROIC)	-4.04%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	371,705
Profits Per Employee	-32,873
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	19.86

Taxes

Income Tax	-19.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.40% in the last 52 weeks. The beta is 1.10, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-12.40%
50-Day Moving Average	8.24
200-Day Moving Average	8.33
Relative Strength Index (RSI)	41.45
Average Volume (20 Days)	60,482

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.40

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 1.88 billion and -166.34 million in losses. Loss per share was -0.95.

Revenue	1.88B
Gross Profit	1.31B
Operating Income	-132.86M
Pretax Income	-186.05M
Net Income	-166.34M
EBITDA	12.03M
EBIT	-132.86M
Loss Per Share	-0.95

Balance Sheet

The company has 540.29 million in cash and 775.24 million in debt, giving a net cash position of -234.95 million.

Cash & Cash Equivalents	540.29M
Total Debt	775.24M
Net Cash	-234.95M
Net Cash Per Share	n/a
Equity (Book Value)	1.04B
Book Value Per Share	5.84
Working Capital	511.58M

Cash Flow

In the last 12 months, operating cash flow was 217.62 million and capital expenditures -9.23 million, giving a free cash flow of 208.39 million.

Operating Cash Flow	217.62M
Capital Expenditures	-9.23M
Free Cash Flow	208.39M
FCF Per Share	n/a

Margins

Gross margin is 69.80%, with operating and profit margins of -7.06% and -8.84%.

Gross Margin	69.80%
Operating Margin	-7.06%
Pretax Margin	-9.89%
Profit Margin	-8.84%
EBITDA Margin	0.64%
EBIT Margin	-7.06%
FCF Margin	11.08%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.59%
Earnings Yield	-16.12%
FCF Yield	20.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.41
Piotroski F-Score	4